Conmed (CNMD) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Conmed (CNMD) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.03 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.39% |
| Dec 31, 2025 | 485.48% |
| Sep 30, 2025 | -86.65% |
| Jun 30, 2025 | 254.89% |
| Mar 31, 2025 | -82.12% |
| Dec 31, 2024 | -31.09% |
| Sep 30, 2024 | 63.41% |
| Jun 30, 2024 | 52.09% |
| Mar 31, 2024 | -40.40% |
| Dec 31, 2023 | 108.82% |
| Sep 30, 2023 | 15.33% |
| Jun 30, 2023 | 654.92% |
| Mar 31, 2023 | -93.16% |
| Dec 31, 2022 | -42.40% |
| Sep 30, 2022 | 127.42% |
| Jun 30, 2022 | -1,223.81% |
| Mar 31, 2022 | -38.74% |
| Dec 31, 2021 | 63.53% |
| Sep 30, 2021 | 12.48% |
| Jun 30, 2021 | 34.79% |